N-[[4-(3-chlorophenyl)oxan-4-yl]methyl]morpholine-3-carboxamide

C17H23ClN2O3 — CID 119749884

IUPACN-[[4-(3-chlorophenyl)oxan-4-yl]methyl]morpholine-3-carboxamide
SMILESO=C(NCC1(c2cccc(Cl)c2)CCOCC1)C1COCCN1
InChIInChI=1S/C17H23ClN2O3/c18-14-3-1-2-13(10-14)17(4-7-22-8-5-17)12-20-16(21)15-11-23-9-6-19-15/h1-3,10,15,19H,4-9,11-12H2,(H,20,21)
InChIKeyLIIOXOXIBOBUBM-UHFFFAOYSA-N
MW338.84 g/mol
LogP1.49
Rot. Bonds4

About N-[[4-(3-chlorophenyl)oxan-4-yl]methyl]morpholine-3-carboxamide

N-[[4-(3-chlorophenyl)oxan-4-yl]methyl]morpholine-3-carboxamide (PubChem CID 119749884) has the molecular formula C17H23ClN2O3 and a molecular weight of 338.84 g/mol. Its IUPAC name is N-[[4-(3-chlorophenyl)oxan-4-yl]methyl]morpholine-3-carboxamide.

Molecular Properties

Compound NameN-[[4-(3-chlorophenyl)oxan-4-yl]methyl]morpholine-3-carboxamide
PubChem CID119749884
Molecular FormulaC17H23ClN2O3
Molecular Weight338.84 g/mol
Exact Mass338.14
IUPAC NameN-[[4-(3-chlorophenyl)oxan-4-yl]methyl]morpholine-3-carboxamide
SMILESO=C(NCC1(c2cccc(Cl)c2)CCOCC1)C1COCCN1
InChIInChI=1S/C17H23ClN2O3/c18-14-3-1-2-13(10-14)17(4-7-22-8-5-17)12-20-16(21)15-11-23-9-6-19-15/h1-3,10,15,19H,4-9,11-12H2,(H,20,21)
InChIKeyLIIOXOXIBOBUBM-UHFFFAOYSA-N
XLogP1.49
TPSA59.59 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds4
Heavy Atoms23
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500338.84
LogP ≤ 51.49
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Analyze N-[[4-(3-chlorophenyl)oxan-4-yl]methyl]morpholine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[[4-(3-bromophenyl)oxan-4-yl]methyl]morpholine-3-carboxamide
CID 119738787
N-[[1-(3-bromophenyl)cyclopropyl]methyl]morpholine-3-carboxamide;hydrochloride
CID 119786264
N-[[4-(3-chlorophenyl)oxan-4-yl]methyl]pyrrolidine-3-carboxamide
CID 119749930
(2S,4S)-N-[[4-(3-chlorophenyl)oxan-4-yl]methyl]-2-methylpiperidine-4-carboxamide
CID 120625684
N-[[1-(3-methoxyphenyl)cyclopentyl]methyl]morpholine-3-carboxamide;hydrochloride
CID 119780111
N-[[1-(4-fluorophenyl)cyclopropyl]methyl]morpholine-3-carboxamide
CID 119731196
N-[[4-(3-chlorophenyl)oxan-4-yl]methyl]-9H-xanthene-9-carboxamide
CID 56581269
(2R,3S)-N-[[1-(3-chlorophenyl)cyclopropyl]methyl]-2-methylmorpholine-3-carboxamide;hydrochloride
CID 120934617
3-amino-N-[[4-(3-chlorophenyl)oxan-4-yl]methyl]cyclopentane-1-carboxamide;hydrochloride
CID 119749889
N-[[1-(4-fluorophenyl)cyclobutyl]methyl]morpholine-3-carboxamide;hydrochloride
CID 119761154
N-[[4-(3-fluorophenyl)oxan-4-yl]methyl]piperazine-2-carboxamide
CID 175658431
(2R)-N-[[4-(3-chlorophenyl)oxan-4-yl]methyl]-2-methylbutanamide
CID 94643933

Frequently Asked Questions

What is the IUPAC name of N-[[4-(3-chlorophenyl)oxan-4-yl]methyl]morpholine-3-carboxamide?
The IUPAC name of N-[[4-(3-chlorophenyl)oxan-4-yl]methyl]morpholine-3-carboxamide (CID 119749884) is N-[[4-(3-chlorophenyl)oxan-4-yl]methyl]morpholine-3-carboxamide.
What is the SMILES notation for N-[[4-(3-chlorophenyl)oxan-4-yl]methyl]morpholine-3-carboxamide?
The canonical SMILES for N-[[4-(3-chlorophenyl)oxan-4-yl]methyl]morpholine-3-carboxamide is O=C(NCC1(c2cccc(Cl)c2)CCOCC1)C1COCCN1.
What is the InChIKey of N-[[4-(3-chlorophenyl)oxan-4-yl]methyl]morpholine-3-carboxamide?
The InChIKey is LIIOXOXIBOBUBM-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H23ClN2O3/c18-14-3-1-2-13(10-14)17(4-7-22-8-5-17)12-20-16(21)15-11-23-9-6-19-15/h1-3,10,15,19H,4-9,11-12H2,(H,20,21).
What are the key properties of N-[[4-(3-chlorophenyl)oxan-4-yl]methyl]morpholine-3-carboxamide?
N-[[4-(3-chlorophenyl)oxan-4-yl]methyl]morpholine-3-carboxamide has a molecular weight of 338.84 g/mol, XLogP of 1.49, 4 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[4-(3-chlorophenyl)oxan-4-yl]methyl]morpholine-3-carboxamide is sourced from PubChem (CID 119749884), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).